BioSpace News Archive

Kiadis Pharma N.V. announces the formation of its Scientific Advisory Board comprised of world-leading experts in the field of oncology and cell therapy.

Vienna-based biotech company PhagoMed Biopharma GmbH has discovered a novel drug candidate for the treatment of Bacterial Vaginosis and the re-stabilization of the vaginal microbiome.

The French company PhinC Development, specialized in simulation and modeling strategy for drug development, strengthens its presence in North America to significantly develop its business and increase its turnover.

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics introduces nano secondary antibodies with high affinity and specificity for global researchers.

New research from the Karolinska Institute has demonstrated the I-DOT’s capability to facilitate genetic research in cancer diagnostics. The Karolinska Institute in Sweden is at the forefront of cancer research in the world.

Low-cost, flexible and dependable automation possibilities open up for any research group

The pharmaceutical company Biogen announced they plan to file for US marketing approval of the potential Alzheimer’s drug, aducanumab.

Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that advanced radiation therapy delivered within PetCure-developed treatment protocols is leading to better survival outcomes than other treatment options for at least nine specific tumor types.

MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM ‘19, last week in Barcelona.